Exhibit 99.2

VCA Antech, Inc. Provides Financial Guidance

    LOS ANGELES--(BUSINESS WIRE)--Oct. 25, 2005--Our company, VCA
Antech, Inc. (NASDAQ:WOOF), a leading animal healthcare company in the
United States, provides financial guidance for all investors in
adherence with Regulation Fair Disclosure as issued by the United
States Securities and Exchange Commission, SEC. We encourage all
current and potential investors to review the disclosure regarding
forward-looking statements in this press release as well as in all
financial documents filed with the SEC.
    We are providing the following financial guidance for the three
months ending December 31, 2005:

    --  Revenue of $211 million to $214 million; and

    --  Diluted earnings per common share of $0.18 to $0.19.

    We are providing the following preliminary financial guidance for
the year ending December 31, 2006:

    --  Revenue of $940 million to $955 million; and

    --  Diluted earnings per common share of $1.03 to $1.06.

    We will adopt Statement of Financial Accounting Standards, or
SFAS, No. 123(R) on January 1, 2006. SFAS No. 123(R) will require us
to expense the cost of share-based payments to employees, including
stock options. The 2006 guidance provided above includes share-based
compensation. We expect share-based compensation of $0.02 per diluted
common share in 2006 based on options granted as of September 30,
2005.

    Forward-Looking Statements

    This press release contains forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995,
including our financial guidance for the fourth quarter of 2005 and
our preliminary guidance for 2006. Such statements are just
predictions and involve risks and uncertainties such that actual
results and performance may differ materially. Factors that might
cause such a difference include: a material adverse change in our
financial condition or operations; the ability to successfully
integrate the Pet's Choice animal hospitals and achieve all of the
expected operating synergies; the rate of our laboratory internal
revenue growth and animal hospital same-store revenue growth; the
level of direct costs and our ability to maintain revenue at a level
necessary to maintain expected operating margins; the level of
selling, general and administrative costs; the effects of competition;
any impairment in the carrying value of our goodwill; the effects of
our recent acquisitions and our ability to effectively manage our
growth; changes in prevailing interest rates; our ability to service
our debt; and general economic conditions. These and other risk
factors are discussed in our periodic reports filed with the SEC,
including our Report on Form 10-K for the year ended December 31, 2004
and our periodic Report on Form 10-Q for the quarter ended June 30,
2005, and the reader is directed to these statements for a further
discussion of important factors that could cause actual results to
differ materially from those in the forward-looking statements.
    We own, operate and manage the largest networks of freestanding
veterinary hospitals and veterinary-exclusive clinical laboratories in
the country, and we supply ultrasound and digital radiography
equipment to the veterinary industry.

    CONTACT: VCA Antech, Inc.
             Tomas Fuller, 310-571-6505